{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:17:39Z","timestamp":1778170659396,"version":"3.51.4"},"reference-count":396,"publisher":"Elsevier","isbn-type":[{"value":"9780443470943","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.acc.2025.10.008","type":"book-chapter","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:02:48Z","timestamp":1763013768000},"page":"1-59","source":"Crossref","is-referenced-by-count":1,"title":["Oncogenesis in cholangiocarcinoma"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.acc.2025.10.008_bib1","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1245\/s10434-021-10650-6","article-title":"Geographic disparities in referral rates and oncologic outcomes of intrahepatic cholangiocarcinoma: a population-based study","volume":"28","author":"Sutton","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib2","doi-asserted-by":"crossref","unstructured":"S. Sarcognato, D. Sacchi, M. Fassan, L. Fabris, M. Cadamuro, G. Zanus, et al., Cholangiocarcinoma, Pathologica. 113 (2021), 158\u201369.","DOI":"10.32074\/1591-951X-252"},{"key":"10.1016\/bs.acc.2025.10.008_bib3","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1245\/s10434-021-09871-6","article-title":"The landmark series: hilar cholangiocarcinoma","volume":"28","author":"Soares","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib4","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1007\/s00261-020-02559-7","article-title":"Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings","volume":"45","author":"Saleh","year":"2020","journal-title":"Abdom.\u00a0Radiol."},{"key":"10.1016\/bs.acc.2025.10.008_bib5","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1007\/s00268-018-4530-0","article-title":"Defining early recurrence of hilar cholangiocarcinoma after curative-intent surgery: a multi-institutional study from the US extrahepatic biliary malignancy consortium","volume":"42","author":"Zhang","year":"2018","journal-title":"World.\u00a0J.\u00a0Surg."},{"issue":"1","key":"10.1016\/bs.acc.2025.10.008_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/liv.14093","article-title":"Anatomical, histomorphological and molecular classification of cholangiocarcinoma","volume":"39","author":"Kendall","year":"2019","journal-title":"Liver Intl."},{"issue":"1","key":"10.1016\/bs.acc.2025.10.008_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12253-018-0491-8","article-title":"Cholangiocarcinoma: classification, histopathology and molecular carcinogenesis","volume":"26","author":"Lendvai","year":"2020","journal-title":"Pathol.\u00a0Oncol. Res."},{"issue":"1","key":"10.1016\/bs.acc.2025.10.008_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/liv.14095","article-title":"Cholangiocarcinoma: epidemiology and risk factors","volume":"39","author":"Khan","year":"2019","journal-title":"Liver Intl."},{"key":"10.1016\/bs.acc.2025.10.008_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nature Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4251\/wjgo.v2.i11.407","article-title":"Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors","volume":"2","author":"Cardinale","year":"2010","journal-title":"World J.\u00a0Gastrointest.\u00a0Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib11","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.3748\/wjg.v20.i19.5721","article-title":"Hepatitis B virus infection and intrahepatic cholangiocarcinoma","volume":"20","author":"Zhou","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/bs.acc.2025.10.008_bib12","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","article-title":"Current epidemiology of cholangiocarcinoma in Western countries","volume":"77","author":"Vithayathil","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/gut.48.6.816","article-title":"Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998","volume":"48","author":"Taylor-Robinson","year":"2001","journal-title":"Gut"},{"key":"10.1016\/bs.acc.2025.10.008_bib14","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/bs.acc.2025.10.008_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2023.102223","article-title":"New epidemiologic trends in cholangiocarcinoma","volume":"47","author":"Pascale","year":"2023","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/bs.acc.2025.10.008_bib16","article-title":"Epidemiology of cholangiocarcinoma","author":"Qurashi","year":"2023","journal-title":"Eur.\u00a0J.\u00a0Surg. Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.21037\/hbsn.2017.01.02","article-title":"Epidemiology and risk factors: intrahepatic cholangiocarcinoma","volume":"6","author":"Gupta","year":"2017","journal-title":"Hepatobil. Surg. Nutr"},{"key":"10.1016\/bs.acc.2025.10.008_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.5009\/gnl16033","article-title":"Biology of Cholangiocytes: from Bench to Bedside","volume":"10","author":"Yoo","year":"2016","journal-title":"Gut.\u00a0Liver"},{"key":"10.1016\/bs.acc.2025.10.008_bib19","article-title":"Physiology, Bile","author":"Almajid","year":"2025","journal-title":"Treasure Island ((FL))"},{"key":"10.1016\/bs.acc.2025.10.008_bib20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/icb.2008.37","article-title":"The immunobiology of cholangiocytes","volume":"86","author":"Chen","year":"2008","journal-title":"Immunol.\u00a0Cell Biol."},{"key":"10.1016\/bs.acc.2025.10.008_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","article-title":"Cholangiocyte pathobiology","volume":"16","author":"Banales","year":"2019","journal-title":"Nature. Rev. Gastroenterol.\u00a0Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.gtc.2017.01.011","article-title":"Hepatic progenitor cells: an update","volume":"46","author":"Van Haele","year":"2017","journal-title":"Gastroenterol.\u00a0Clin. No Am."},{"key":"10.1016\/bs.acc.2025.10.008_bib23","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.ajpath.2015.06.004","article-title":"Hepatic progenitor cells in action: liver regeneration or fibrosis?","volume":"185","author":"Kaur","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/bs.acc.2025.10.008_bib24","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/hep.24590","article-title":"Multipotent stem\/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets","volume":"54","author":"Cardinale","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/bs.acc.2025.10.008_bib25","doi-asserted-by":"crossref","unstructured":"G. Carpino, V. Cardinale, P. Onori, A. Franchitto, P.B. Berloco, M. Rossi, et al., Biliary tree stem\/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages. J. Anat. 220 (2012), 186\u201399.","DOI":"10.1111\/j.1469-7580.2011.01462.x"},{"key":"10.1016\/bs.acc.2025.10.008_bib26","first-page":"223","article-title":"Neoplastic diseases of the papilla of Vater","volume":"11","author":"Kimura","year":"2004","journal-title":"J.\u00a0Hepato-Biliary-Pancreatic Surg."},{"key":"10.1016\/bs.acc.2025.10.008_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4251\/wjgo.v4.i5.94","article-title":"Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity","volume":"4","author":"Cardinale","year":"2012","journal-title":"World J.\u00a0Gastrointest.\u00a0Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib28","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","article-title":"Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features","volume":"27","author":"Liau","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/bs.acc.2025.10.008_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4254\/wjh.v2.i12.419","article-title":"Pathological classification of intrahepatic cholangiocarcinoma based on a new concept","volume":"2","author":"Nakanuma","year":"2010","journal-title":"World J.\u00a0Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib30","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/PAS.0000000000000670","article-title":"Distinct clinicopathologic and genetic features of 2 histologic subtypes of intrahepatic cholangiocarcinoma","volume":"40","author":"Hayashi","year":"2016","journal-title":"Am.\u00a0J.\u00a0Surg. Pathol."},{"key":"10.1016\/bs.acc.2025.10.008_bib31","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/modpathol.2017.22","article-title":"Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas","volume":"30","author":"Akita","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/bs.acc.2025.10.008_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bpg.2015.02.006","article-title":"Pathologic classification of cholangiocarcinoma: New concepts","volume":"29","author":"Nakanuma","year":"2015","journal-title":"Best Practice\u00a0Research. Clin.\u00a0Gastroenterol."},{"key":"10.1016\/bs.acc.2025.10.008_bib33","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/hep.25595","article-title":"Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes","volume":"55","author":"Komuta","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/bs.acc.2025.10.008_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jhep.2014.09.007","article-title":"Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts","volume":"62","author":"Raggi","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib35","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Ilyas","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.acc.2025.10.008_bib36","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/gutjnl-2012-304351","article-title":"Keratin 19: a key role player in the invasion of human hepatocellular carcinomas","volume":"63","author":"Govaere","year":"2014","journal-title":"Gut"},{"key":"10.1016\/bs.acc.2025.10.008_bib37","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/hep.26711","article-title":"Liver-specific knockout of GRP94 in mice disrupts cell adhesion, activates liver progenitor cells, and accelerates liver tumorigenesis","volume":"59","author":"Chen","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/bs.acc.2025.10.008_bib38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4254\/wjh.v5.i8.425","article-title":"Participation of peribiliary glands in biliary tract pathophysiologies","volume":"5","author":"Igarashi","year":"2013","journal-title":"World J. Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib39","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.ajpath.2015.02.010","article-title":"Profiles of cancer stem cell subpopulations in cholangiocarcinomas","volume":"185","author":"Cardinale","year":"2015","journal-title":"Am J. Pathol."},{"key":"10.1016\/bs.acc.2025.10.008_bib40","first-page":"1","article-title":"Proposal of a new disease concept \u201cbiliary diseases with pancreatic counterparts\u201d. Anatomical and pathological bases","volume":"29","author":"Nakanuma","year":"2014","journal-title":"Histol Histopathol."},{"key":"10.1016\/bs.acc.2025.10.008_bib41","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/hep.25587","article-title":"Mucin-producing cholangiocarcinoma might derive from biliary tree stem\/progenitor cells located in peribiliary glands","volume":"55","author":"Cardinale","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/bs.acc.2025.10.008_bib42","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jhep.2015.06.018","article-title":"Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis","volume":"63","author":"Carpino","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.path.2018.02.005","article-title":"Cholangiocarcinoma","volume":"11","author":"Krasinskas","year":"2018","journal-title":"Surg. Pathol. Clin."},{"key":"10.1016\/bs.acc.2025.10.008_bib44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00428-014-1537-2","article-title":"Cystic and micropapillary epithelial changes of peribiliary glands might represent a precursor lesion of biliary epithelial neoplasms","volume":"464","author":"Sato","year":"2014","journal-title":"Virchows Arch."},{"key":"10.1016\/bs.acc.2025.10.008_bib45","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.25590","article-title":"Cystic and papillary neoplasm involving peribiliary glands: a biliary counterpart of branch-type intraductal papillary mucinous [corrected] neoplasm?","volume":"55","author":"Nakanuma","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/bs.acc.2025.10.008_bib46","first-page":"33","article-title":"Cells of origin and cancer stem cells in cholangiocarcinoma","author":"Carpino","year":"2021","journal-title":"Transl.\u00a0Gastrointest Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib47","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3390\/jcm12020709","article-title":"KRAS mutations in solid tumors: characteristics, current therapeutic strategy, and potential treatment exploration","volume":"12","author":"Yang","year":"2023","journal-title":"J. Clin.\u00a0Med."},{"key":"10.1016\/bs.acc.2025.10.008_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/cancers8040045","article-title":"KRAS mutant pancreatic cancer: no lone path to an effective treatment","volume":"8","author":"Zeitouni","year":"2016","journal-title":"Cancers"},{"key":"10.1016\/bs.acc.2025.10.008_bib49","article-title":"Light at the end of the tunnel: Clinical features and therapeutic prospects of KRAS mutant subtypes in non-small-cell lung cancer","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Gen."},{"key":"10.1016\/bs.acc.2025.10.008_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119499","article-title":"Interplay between MAPK\/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression","volume":"278","author":"Asl","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/bs.acc.2025.10.008_bib51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/bs.acc.2025.10.008_bib52","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.9840","article-title":"KRAS allelic variants in biliary tract cancers","volume":"7","author":"Moffat","year":"2024","journal-title":"JAMA Network Open"},{"key":"10.1016\/bs.acc.2025.10.008_bib53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41698-022-00334-z","article-title":"Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors","volume":"6","author":"Lee","year":"2022","journal-title":"NPJ Precision Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib54","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ccell.2020.04.012","article-title":"Comprehensive analysis of genetic ancestry and its molecular correlates in cancer","volume":"37","author":"Carrot-Zhang","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.acc.2025.10.008_bib55","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/liv.15366","article-title":"KRAS mutation in intrahepatic cholangiocarcinoma: Linkage with metastasis-free survival and reduced E-cadherin expression","volume":"42","author":"Tanaka","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/bs.acc.2025.10.008_bib56","first-page":"795","article-title":"B-raf and a B-raf pseudogene are located on 7q in man","volume":"7","author":"Sithanandam","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/bs.acc.2025.10.008_bib57","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.advenzreg.2006.01.004","article-title":"Roles of the RAF\/MEK\/ERK and PI3K\/PTEN\/AKT pathways in malignant transformation and drug resistance","volume":"46","author":"McCubrey","year":"2006","journal-title":"Adv.\u00a0Enzyme. Regul."},{"key":"10.1016\/bs.acc.2025.10.008_bib58","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib","volume":"366","author":"Sosman","year":"2012","journal-title":"NEJM"},{"key":"10.1016\/bs.acc.2025.10.008_bib59","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/bs.acc.2025.10.008_bib60","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2020.03.008","article-title":"Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma","volume":"73","author":"Montal","year":"2020","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib61","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3390\/cancers12082039","article-title":"Targeted therapies in advanced biliary tract cancer: an evolving paradigm","volume":"12","author":"Chakrabarti","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/bs.acc.2025.10.008_bib62","article-title":"BRAF mutation in Chinese biliary tract cancer patients","volume":"38","author":"Li","year":"2025","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib63","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.humpath.2013.07.026","article-title":"The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome","volume":"44","author":"Robertson","year":"2013","journal-title":"Hum. Pathol."},{"key":"10.1016\/bs.acc.2025.10.008_bib64","doi-asserted-by":"crossref","first-page":"9193","DOI":"10.1073\/pnas.86.23.9193","article-title":"Isolation and characterization of ERBB3, a third member of the ERBB\/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors","volume":"86","author":"Kraus","year":"1989","journal-title":"Proc. Natl.\u00a0Acad. Sci.\u00a0USA"},{"issue":"8","key":"10.1016\/bs.acc.2025.10.008_bib65","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1172\/JCI32278","article-title":"ErbB receptors: from oncogenes to targeted cancer therapies","volume":"117","author":"Zhang","year":"2007","journal-title":"J. Clin. Invest"},{"key":"10.1016\/bs.acc.2025.10.008_bib66","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/emboj\/16.7.1647","article-title":"ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling","volume":"16","author":"Graus-Porta","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/bs.acc.2025.10.008_bib67","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nsb0303-158","article-title":"Ready to partner","volume":"10","author":"Sliwkowski","year":"2003","journal-title":"Nature Struct. Biol."},{"key":"10.1016\/bs.acc.2025.10.008_bib68","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/j.1460-2075.1996.tb00356.x","article-title":"ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer","volume":"15","author":"Karunagaran","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/bs.acc.2025.10.008_bib69","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10555-016-9649-6","article-title":"The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer","volume":"35","author":"Hsu","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/bs.acc.2025.10.008_bib70","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc1609","article-title":"ERBB receptors and cancer: the complexity of targeted inhibitors","volume":"5","author":"Hynes","year":"2005","journal-title":"Nature Rev. Cancer."},{"key":"10.1016\/bs.acc.2025.10.008_bib71","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10555-016-9645-x","article-title":"HER2\/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?","volume":"36","author":"Galdy","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/bs.acc.2025.10.008_bib72","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/modpathol.2015.57","article-title":"Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2)","volume":"28","author":"Hechtman","year":"2015","journal-title":"Mod Pathol."},{"key":"10.1016\/bs.acc.2025.10.008_bib73","first-page":"2958","article-title":"A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor","volume":"7","author":"Ciardiello","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib74","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jhep.2014.03.033","article-title":"EGF\/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition","volume":"61","author":"Clap\u00e9ron","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib75","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2147\/OTT.S36213","article-title":"Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma","volume":"5","author":"Yao","year":"2012","journal-title":"Onco\u00a0Targets Ther."},{"key":"10.1016\/bs.acc.2025.10.008_bib76","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.humpath.2012.07.004","article-title":"Overexpression of epithelial-mesenchymal transition-related markers according to cell dedifferentiation: clinical implications as an independent predictor of poor prognosis in cholangiocarcinoma","volume":"43","author":"Ryu","year":"2012","journal-title":"Hum Pathol."},{"key":"10.1016\/bs.acc.2025.10.008_bib77","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00428-012-1321-0","article-title":"HER3 overexpression is a prognostic indicator of extrahepatic cholangiocarcinoma","volume":"461","author":"Lee","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1016\/bs.acc.2025.10.008_bib78","first-page":"42","article-title":"Overexpression of the HER2\/neu gene: a new therapeutic possibility for patients with advanced gallbladder cancer","volume":"7","author":"Roa","year":"2014","journal-title":"Gastroint Cancer Res"},{"key":"10.1016\/bs.acc.2025.10.008_bib79","first-page":"700","article-title":"Characterization of EGFR family gene aberrations in cholangiocarcinoma","volume":"32","author":"Yang","year":"2014","journal-title":"Oncol.\u00a0Rep."},{"key":"10.1016\/bs.acc.2025.10.008_bib80","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1073\/pnas.88.16.7001","article-title":"Evidence for the identity of human scatter factor and human hepatocyte growth factor","volume":"88","author":"Weidner","year":"1991","journal-title":"Proc.\u00a0Natl.\u00a0Acad. Sci.\u00a0USA"},{"key":"10.1016\/bs.acc.2025.10.008_bib81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.compstruct.2018.04.021","article-title":"Dynamic compressive response of additively manufactured AlSi10Mg alloy hierarchical honeycomb structures","volume":"195","author":"Zhang","year":"2018","journal-title":"Comp. Struct."},{"key":"10.1016\/bs.acc.2025.10.008_bib82","doi-asserted-by":"crossref","first-page":"21267","DOI":"10.1074\/jbc.M800727200","article-title":"A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met","volume":"283","author":"Basilico","year":"2008","journal-title":"J.\u00a0Biol.\u00a0Chem."},{"key":"10.1016\/bs.acc.2025.10.008_bib83","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1177\/1758834011422556","article-title":"An overview of the c-MET signaling pathway","volume":"3","author":"Organ","year":"2011","journal-title":"Ther. Adv.\u00a0Med. Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib84","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/bs.acc.2025.10.008_bib85","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1634\/theoncologist.2011-0386","article-title":"Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping","volume":"17","author":"Borger","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/bs.acc.2025.10.008_bib86","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation","volume":"18","author":"Figueroa","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.acc.2025.10.008_bib87","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.acc.2025.10.008_bib88","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12885-020-06804-6","article-title":"Distinct clinical and prognostic implication of IDH1\/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma","volume":"20","author":"Ma","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib89","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1634\/theoncologist.2015-0210","article-title":"Prognosis and Clinicopathologic Features of Patients with Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma","volume":"20","author":"Goyal","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/bs.acc.2025.10.008_bib90","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1038\/onc.2012.315","article-title":"Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas","volume":"32","author":"Wang","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/bs.acc.2025.10.008_bib91","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/gcc.20540","article-title":"Rare PIK3CA hotspot mutations in carcinomas of the biliary tract","volume":"47","author":"Riener","year":"2008","journal-title":"Genes. Chrom. Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib92","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1038\/onc.2010.236","article-title":"The role of signaling pathways in the development and treatment of hepatocellular carcinoma","volume":"29","author":"Whittaker","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/bs.acc.2025.10.008_bib93","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ccr.2005.05.014","article-title":"Mutant PIK3CA promotes cell growth and invasion of human cancer cells","volume":"7","author":"Samuels","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.acc.2025.10.008_bib94","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ncb810","article-title":"Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils","volume":"4","author":"Wang","year":"2002","journal-title":"Nature Cell. Biol."},{"key":"10.1016\/bs.acc.2025.10.008_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003068","article-title":"Synthetic activation of endogenous PI3K and Rac identifies an AND-gate switch for cell polarization and migration","volume":"3","author":"Inoue","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/bs.acc.2025.10.008_bib96","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.biopha.2010.06.009","article-title":"KRAS and PIK3CA but not BRAF genes are frequently mutated in Chinese cholangiocarcinoma patients","volume":"65","author":"Feng","year":"2011","journal-title":"Biomed.\u00a0Pharmacother."},{"key":"10.1016\/bs.acc.2025.10.008_bib97","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","article-title":"Putting p53 in Context","volume":"170","author":"Kastenhuber","year":"2017","journal-title":"Cell"},{"key":"10.1016\/bs.acc.2025.10.008_bib98","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1038\/sj.onc.1202576","article-title":"Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress","volume":"17","author":"Amundson","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/bs.acc.2025.10.008_bib99","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3390\/genes15050577","article-title":"Comprehensive bioinformatic investigation of TP53 dysregulation in diverse cancer landscapes","volume":"15","author":"Khan","year":"2024","journal-title":"Genes"},{"key":"10.1016\/bs.acc.2025.10.008_bib100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1634\/theoncologist.2013-0352","article-title":"New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing","volume":"19","author":"Ross","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/bs.acc.2025.10.008_bib101","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.critrevonc.2016.08.013","article-title":"Molecular characteristics of biliary tract cancer","volume":"107","author":"Sohal","year":"2016","journal-title":"Crit. Rev. Oncolog\/Hematol."},{"key":"10.1016\/bs.acc.2025.10.008_bib102","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/ng.2806","article-title":"Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers","volume":"45","author":"Chan-On","year":"2013","journal-title":"Nature Gen."},{"key":"10.1016\/bs.acc.2025.10.008_bib103","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1016\/j.celrep.2017.02.033","article-title":"Integrative genomic analysis of cholangiocarcinoma identifies distinct idh-mutant molecular profiles","volume":"18","author":"Farshidfar","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/bs.acc.2025.10.008_bib104","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cell.2014.05.051","article-title":"p53-dependent Nestin regulation links tumor suppression to cellular plasticity in iver cancer","volume":"158","author":"Tschaharganeh","year":"2014","journal-title":"Cell"},{"key":"10.1016\/bs.acc.2025.10.008_bib105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12967-020-02437-2","article-title":"Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience","volume":"18","author":"Wang","year":"2020","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/bs.acc.2025.10.008_bib106","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003214","article-title":"Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes","volume":"9","author":"Chen","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib107","article-title":"TP53 \/KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma","volume":"13","author":"Guo","year":"2022","journal-title":"Front Gen."},{"key":"10.1016\/bs.acc.2025.10.008_bib108","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF03401664","article-title":"The CDKN2A (p16) gene and human cancer","volume":"3","author":"Foulkes","year":"1997","journal-title":"Mol Med."},{"key":"10.1016\/bs.acc.2025.10.008_bib109","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2217\/epi.10.9","article-title":"Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies","volume":"2","author":"Hamilton","year":"2010","journal-title":"Epigenomics"},{"key":"10.1016\/bs.acc.2025.10.008_bib110","first-page":"42","article-title":"A novel targeted therapy in breast cancer: cyclin dependent kinase inhibitors","volume":"19","author":"Akin","year":"2014","journal-title":"J.\u00a0BUON"},{"key":"10.1016\/bs.acc.2025.10.008_bib111","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/path.2345","article-title":"Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis","volume":"215","author":"Sasaki","year":"2008","journal-title":"J Pathol."},{"key":"10.1016\/bs.acc.2025.10.008_bib112","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.humpath.2008.11.002","article-title":"Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma","volume":"40","author":"Chinnasri","year":"2009","journal-title":"Hum Pathol."},{"key":"10.1016\/bs.acc.2025.10.008_bib113","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/jhbp.126","article-title":"Molecular mechanism of cholangiocarcinoma carcinogenesis","volume":"21","author":"Maemura","year":"2014","journal-title":"J. Hepato-Biliary-Pancreatic. Sci."},{"key":"10.1016\/bs.acc.2025.10.008_bib114","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7150\/ijbs.23230","article-title":"The role of TGF-\u03b2\/SMAD4 signaling in cancer","volume":"14","author":"Zhao","year":"2018","journal-title":"Intl.\u00a0J. Biol.\u00a0Sci."},{"key":"10.1016\/bs.acc.2025.10.008_bib115","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/gutjnl-2018-317163","article-title":"Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer","volume":"69","author":"Liang","year":"2020","journal-title":"Gut"},{"key":"10.1016\/bs.acc.2025.10.008_bib116","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050358","article-title":"Smad4 restricts injury-provoked biliary proliferation and carcinogenesis","volume":"17","author":"Alexander","year":"2024","journal-title":"Dis Models Mech"},{"key":"10.1016\/bs.acc.2025.10.008_bib117","first-page":"3176","article-title":"SMAD4 gene mutation renders pancreatic cancer resistance to radiotherapy through promotion of autophagy","volume":"24","author":"Wang","year":"2018","journal-title":"Clin.\u00a0Cancer.\u00a0Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib118","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1038\/s41467-018-06654-8","article-title":"TGF-\u03b2-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure","volume":"9","author":"Chakravarthy","year":"2018","journal-title":"Nature Comm."},{"key":"10.1016\/bs.acc.2025.10.008_bib119","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/hep.31862","article-title":"Molecular characterization of biliary tract cancer predicts chemotherapy and programmed death 1\/programmed death-ligand 1 blockade responses","volume":"74","author":"Yoon","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/bs.acc.2025.10.008_bib120","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1111\/jcmm.17857","article-title":"SMAD4 regulates the progression of cholangiocarcinoma by modulating the expression of STING1","volume":"27","author":"Shi","year":"2023","journal-title":"J.\u00a0Cell. Mol.\u00a0Med."},{"key":"10.1016\/bs.acc.2025.10.008_bib121","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41418-021-00897-7","article-title":"The Smad4-MYO18A-PP1A complex regulates \u03b2-catenin phosphorylation and pemigatinib resistance by inhibiting PAK1 in cholangiocarcinoma","volume":"29","author":"Liu","year":"2022","journal-title":"Cell Death Diff."},{"key":"10.1016\/bs.acc.2025.10.008_bib122","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12957-022-02747-3","article-title":"Prognostic value of functional SMAD4 localization in extrahepatic bile duct cancer","volume":"20","author":"Takayama","year":"2022","journal-title":"World J.\u00a0Surg.\u00a0Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib123","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.tig.2014.05.001","article-title":"A rationale to target the SWI\/SNF complex for cancer therapy","volume":"30","author":"Hohmann","year":"2014","journal-title":"Trends Gen."},{"key":"10.1016\/bs.acc.2025.10.008_bib124","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.tig.2020.07.011","article-title":"Mammalian SWI\/SNF chromatin remodeling complexes: emerging mechanisms and therapeutic strategies","volume":"36","author":"Centore","year":"2020","journal-title":"Trends Gen."},{"key":"10.1016\/bs.acc.2025.10.008_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102287","article-title":"Targeting ARID1A mutations in cancer","volume":"100","author":"Mullen","year":"2021","journal-title":"Cancer Treatment Rev."},{"key":"10.1016\/bs.acc.2025.10.008_bib126","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"NEJM"},{"key":"10.1016\/bs.acc.2025.10.008_bib127","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12885-019-5429-3","article-title":"High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study","volume":"19","author":"Bi","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib128","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.3748\/wjg.v22.i25.5814","article-title":"Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma","volume":"22","author":"Yang","year":"2016","journal-title":"World J.\u00a0Gastroenterol."},{"key":"10.1016\/bs.acc.2025.10.008_bib129","first-page":"7119","article-title":"Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma","volume":"8","author":"Simbolo","year":"2018","journal-title":"Sci.\u00a0Rep."},{"key":"10.1016\/bs.acc.2025.10.008_bib130","article-title":"ARID1A alterations and their clinical significance in cholangiocarcinoma","volume":"8","author":"Namjan","year":"2020","journal-title":"Peer.\u00a0J."},{"key":"10.1016\/bs.acc.2025.10.008_bib131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115383","article-title":"Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications","volume":"9","author":"Churi","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/bs.acc.2025.10.008_bib132","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/ajcp\/aqw071","article-title":"Loss of ARID1A expression presents a novel pathway of carcinogenesis in biliary carcinomas","volume":"145","author":"Sasaki","year":"2016","journal-title":"Am J.\u00a0Clin. Pathol."},{"key":"10.1016\/bs.acc.2025.10.008_bib133","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","article-title":"Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention","volume":"24","author":"Lowery","year":"2018","journal-title":"Clin Cancer Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib134","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1158\/0008-5472.CAN-13-3109","article-title":"Germline mutations in BAP1 impair its function in DNA double-strand break repair","volume":"74","author":"Ismail","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib135","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","article-title":"BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression","volume":"16","author":"Jensen","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/bs.acc.2025.10.008_bib136","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1 and cancer","volume":"13","author":"Carbone","year":"2013","journal-title":"Nature Rev. Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib137","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41419-018-1087-7","article-title":"BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1\/2 and JNK\/c-Jun pathways","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/bs.acc.2025.10.008_bib138","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcae045","article-title":"Expanded detection and impact of BAP1 alterations in cancer","volume":"6","author":"Sturgill","year":"2024","journal-title":"NAR Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib139","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.biochi.2008.10.019","article-title":"Polybromo-1: the chromatin targeting subunit of the PBAF complex","volume":"91","author":"Thompson","year":"2009","journal-title":"Biochimie"},{"key":"10.1016\/bs.acc.2025.10.008_bib140","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.18632\/oncotarget.1943","article-title":"Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups","volume":"5","author":"Simbolo","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/bs.acc.2025.10.008_bib141","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.molcel.2014.06.028","article-title":"Requirement for PBAF in transcriptional repression and repair at DNA breaks in actively transcribed regions of chromatin","volume":"55","author":"Kakarougkas","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/bs.acc.2025.10.008_bib142","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/his.13127","article-title":"Intrahepatic cholangiocarcinoma frequently shows loss of BAP1 and PBRM1 expression, and demonstrates specific clinicopathological and genetic characteristics with BAP1 loss","volume":"70","author":"Misumi","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/bs.acc.2025.10.008_bib143","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ng.2813","article-title":"Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas","volume":"45","author":"Jiao","year":"2013","journal-title":"Nature Gen."},{"key":"10.1016\/bs.acc.2025.10.008_bib144","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/his.13234","article-title":"PBRM1 loss is a late event during the development of cholangiocarcinoma","volume":"71","author":"Luchini","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/bs.acc.2025.10.008_bib145","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","article-title":"Targeting PI3K signalling in cancer: opportunities, challenges and limitations","volume":"9","author":"Engelman","year":"2009","journal-title":"Nature Rev. Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib146","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/bs.acc.2025.10.008_bib147","doi-asserted-by":"crossref","first-page":"45643","DOI":"10.1074\/jbc.M404097200","article-title":"Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1alpha, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase\/AKT signaling","volume":"279","author":"Skinner","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.acc.2025.10.008_bib148","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2010.10.031","article-title":"AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity","volume":"19","author":"Chandarlapaty","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.acc.2025.10.008_bib149","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1158\/2159-8290.CD-11-0085","article-title":"mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling","volume":"1","author":"Rodrik-Outmezguine","year":"2011","journal-title":"Cancer Disc."},{"key":"10.1016\/bs.acc.2025.10.008_bib150","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1039\/C5MB00101C","article-title":"The PI3K\/AKT\/mTOR interactive pathway","volume":"11","author":"Ersahin","year":"2015","journal-title":"Mol. BioSyst."},{"key":"10.1016\/bs.acc.2025.10.008_bib151","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1126\/science.277.5325.567","article-title":"Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B","volume":"277","author":"Stokoe","year":"1997","journal-title":"Science"},{"key":"10.1016\/bs.acc.2025.10.008_bib152","first-page":"161","article-title":"PDK1, the master regulator of AGC kinase signal transduction","volume":"15","author":"Mora","year":"2004","journal-title":"Sem. Cell\u00a0Dev.\u00a0Biol."},{"key":"10.1016\/bs.acc.2025.10.008_bib153","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/bs.acc.2025.10.008_bib154","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/nm759","article-title":"PKB\/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization","volume":"8","author":"Shin","year":"2002","journal-title":"Nature Med"},{"key":"10.1016\/bs.acc.2025.10.008_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216179","article-title":"Glucose transporter 4: Insulin response mastermind, glycolysis catalyst and treatment direction for cancer progression","volume":"563","author":"Chang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/bs.acc.2025.10.008_bib156","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nature Cell Biol."},{"key":"10.1016\/bs.acc.2025.10.008_bib157","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"key":"10.1016\/bs.acc.2025.10.008_bib158","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/bs.acc.2025.10.008_bib159","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/bs.acc.2025.10.008_bib160","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nature Gen."},{"key":"10.1016\/bs.acc.2025.10.008_bib161","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pathol.2015.11.011","article-title":"EGFR, COX2, p-AKT expression and PIK3CA mutation in distal extrahepatic bile duct carcinoma","volume":"48","author":"Moon","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/bs.acc.2025.10.008_bib162","first-page":"2","article-title":"Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers","volume":"8","author":"Papadopoulou","year":"2018","journal-title":"Am. J.\u00a0Cancer Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib163","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/sj.bjc.6604498","article-title":"Analysis of oncogenic AKT1 p.E17K mutation in carcinomas of the biliary tract and liver","volume":"99","author":"Riener","year":"2008","journal-title":"Brit.\u00a0J. Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib164","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1756-9966-28-65","article-title":"Expression of phospho-ERK1\/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations","volume":"28","author":"Li","year":"2009","journal-title":"J. Exp.\u00a0Clin. Cancer Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib165","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00535-007-2055-7","article-title":"Frequent activation of mitogen-activated protein kinase relative to Akt in extrahepatic biliary tract cancer","volume":"42","author":"Hori","year":"2007","journal-title":"J. Gastroenterol."},{"key":"10.1016\/bs.acc.2025.10.008_bib166","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/1471-2407-10-631","article-title":"Targeting EGFR\/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas","volume":"10","author":"Pignochino","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib167","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/j.1440-1746.2006.04373.x","article-title":"Akt expression may predict favorable prognosis in cholangiocarcinoma","volume":"21","author":"Javle","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib168","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.3748\/wjg.v13.i48.6470","article-title":"AKT and ERK1\/2 signaling in intrahepatic cholangiocarcinoma","volume":"13","author":"Schmitz","year":"2007","journal-title":"World J.\u00a0Gastroenterol."},{"key":"10.1016\/bs.acc.2025.10.008_bib169","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1158\/1078-0432.CCR-08-1084","article-title":"The expression of phospho-AKT, phospho-mTOR, and PTEN in extrahepatic cholangiocarcinoma","volume":"15","author":"Chung","year":"2009","journal-title":"Clin.\u00a0Cancer Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/modpathol.2011.133","article-title":"The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas","volume":"25","author":"Lee","year":"2012","journal-title":"Mod.\u00a0Pathol."},{"key":"10.1016\/bs.acc.2025.10.008_bib171","doi-asserted-by":"crossref","first-page":"552","DOI":"10.5858\/arpa.2012-0032-OA","article-title":"Immunohistochemical expression of phospho-mTOR is associated with poor prognosis in patients with gallbladder adenocarcinoma","volume":"137","author":"Leal","year":"2013","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/bs.acc.2025.10.008_bib172","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4149\/neo_2012_018","article-title":"Immunohistochemical analysis of the mTOR pathway in intrahepatic cholangiocarcinoma","volume":"59","author":"Wang","year":"2012","journal-title":"Neoplasma"},{"key":"10.1016\/bs.acc.2025.10.008_bib173","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1158\/1078-0432.CCR-07-0738","article-title":"Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma","volume":"13","author":"Herberger","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib174","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13000-015-0381-2","article-title":"Inactivation of tumor suppressor gene pten in early and advanced gallbladder cancer","volume":"10","author":"Roa","year":"2015","journal-title":"Diag. Pathol."},{"key":"10.1016\/bs.acc.2025.10.008_bib175","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12029-017-9919-8","article-title":"Epigenetic downregulation of PTEN in gallbladder cancer","volume":"48","author":"Tekcham","year":"2017","journal-title":"J.\u00a0Gastrointest.\u00a0Cancer"},{"issue":"8","key":"10.1016\/bs.acc.2025.10.008_bib176","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.prp.2011.05.010","article-title":"Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma","volume":"207","author":"Liu","year":"2011","journal-title":"Pathol.\u00a0Res.\u00a0Pract."},{"key":"10.1016\/bs.acc.2025.10.008_bib177","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ctrv.2018.11.001","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives","volume":"72","author":"Corti","year":"2019","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/bs.acc.2025.10.008_bib178","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/cncr.33364","article-title":"Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers","volume":"127","author":"Tan","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib179","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.3390\/ijms22073464","article-title":"PI3K inhibitors in cancer: clinical implications and adverse effects","volume":"22","author":"Mishra","year":"2021","journal-title":"Int. J.\u00a0Mol. Sci."},{"key":"10.1016\/bs.acc.2025.10.008_bib180","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/medicina55020042","article-title":"Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials","volume":"55","author":"Simile","year":"2019","journal-title":"Medicina"},{"key":"10.1016\/bs.acc.2025.10.008_bib181","article-title":"Dual inhibition of mTORC1\/2 reduces migration of cholangiocarcinoma cells by regulation of matrixmetalloproteinases","volume":"9","author":"Joechle","year":"2021","journal-title":"Front.\u00a0Cell Dev. Biol."},{"key":"10.1016\/bs.acc.2025.10.008_bib182","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3390\/ijms20030500","article-title":"mTOR inhibitors in advanced biliary tract cancers","volume":"20","author":"Wu","year":"2019","journal-title":"Int. J.\u00a0Mol. Sci."},{"key":"10.1016\/bs.acc.2025.10.008_bib183","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/cancers13071538","article-title":"Mechanisms of resistance to PI3K inhibitors in cancer: adaptive responses, drug tolerance and cellular plasticity","volume":"13","author":"Wright","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/bs.acc.2025.10.008_bib184","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","article-title":"Targeting PI3K in cancer: mechanisms and advances in clinical trials","volume":"18","author":"Yang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e31112","article-title":"Dual blockage of PI3K-mTOR and FGFR induced autophagic cell death in cholangiocarcinoma cells","volume":"10","author":"Mahaamnad","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/bs.acc.2025.10.008_bib186","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s10637-014-0149-7","article-title":"Dual inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-inhibitors","volume":"32","author":"Ewald","year":"2014","journal-title":"Invest.\u00a0New Drugs"},{"key":"10.1016\/bs.acc.2025.10.008_bib187","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-60761-795-2_1","article-title":"The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions","volume":"661","author":"Keshet","year":"2010","journal-title":"Meth. Mol.\u00a0Biol."},{"key":"10.1016\/bs.acc.2025.10.008_bib188","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bbamcr.2010.12.012","article-title":"The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation","volume":"1813","author":"Plotnikov","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/bs.acc.2025.10.008_bib189","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.smim.2014.02.009","article-title":"TNF and MAP kinase signalling pathways","volume":"26","author":"Sabio","year":"2014","journal-title":"Sem. Immunol."},{"key":"10.1016\/bs.acc.2025.10.008_bib190","first-page":"1997","article-title":"ERK\/MAPK signalling pathway and tumorigenesis","volume":"19","author":"Guo","year":"2020","journal-title":"Exp. Ther.\u00a0Med."},{"key":"10.1016\/bs.acc.2025.10.008_bib191","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/biom14030259","article-title":"The configuration of GRB2 in protein interaction and signal transduction","volume":"14","author":"Wang","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/bs.acc.2025.10.008_bib192","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1091\/mbc.e04-09-0832","article-title":"Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis","volume":"16","author":"Huang","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/bs.acc.2025.10.008_bib193","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3389\/fonc.2019.01088","article-title":"A comparative analysis of individual RAS mutations in cancer biology","volume":"9","author":"Mu\u00f1oz-Maldonado","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib194","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbrc.2010.07.092","article-title":"RAF protein-serine\/threonine kinases: structure and regulation","volume":"399","author":"Roskoski","year":"2010","journal-title":"Biochem.\u00a0Biophy. Res. Comm."},{"key":"10.1016\/bs.acc.2025.10.008_bib195","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2019.01.039","article-title":"Targeting ERK1\/2 protein-serine\/threonine kinases in human cancers","volume":"142","author":"Roskoski","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib196","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/cancers11040513","article-title":"Divergent dynamics and functions of ERK MAP kinase signaling in development, homeostasis and cancer: lessons from fluorescent bioimaging","volume":"11","author":"Muta","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/bs.acc.2025.10.008_bib197","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ncb822","article-title":"Molecular interpretation of ERK signal duration by immediate early gene products","volume":"4","author":"Murphy","year":"2002","journal-title":"Nature Cell Biol"},{"key":"10.1016\/bs.acc.2025.10.008_bib198","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.1038\/sj.onc.1203362","article-title":"ERK activation induces phosphorylation of Elk-1 at multiple S\/T-P motifs to high stoichiometry","volume":"18","author":"Cruzalegui","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/bs.acc.2025.10.008_bib199","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1006\/jmcc.2000.1185","article-title":"Phosphorylation of elk-1 by MEK\/ERK pathway is necessary for c-fos gene activation during cardiac myocyte hypertrophy","volume":"32","author":"Babu","year":"2000","journal-title":"J.\u00a0Mol. Cell Cardiol."},{"key":"10.1016\/bs.acc.2025.10.008_bib200","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcdb.2016.01.009","article-title":"The regulation of oncogenic Ras\/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs)","volume":"50","author":"Kidger","year":"2016","journal-title":"Sem.\u00a0Cell Dev. Biol."},{"key":"10.1016\/bs.acc.2025.10.008_bib201","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1006\/bbrc.2001.5295","article-title":"ERK pathway positively regulates the expression of Sprouty genes","volume":"285","author":"Ozaki","year":"2001","journal-title":"Biochem.\u00a0Biophys. Res. Comm."},{"key":"10.1016\/bs.acc.2025.10.008_bib202","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/ncb867","article-title":"Sprouty1 and Sprouty2 provide a control mechanism for the Ras\/MAPK signalling pathway","volume":"4","author":"Hanafusa","year":"2002","journal-title":"Nature C Biol."},{"key":"10.1016\/bs.acc.2025.10.008_bib203","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.3390\/cancers14184370","article-title":"The impact of KRAS mutational status on long-term survival following liver resection for hilar cholangiocarcinoma","volume":"14","author":"Ardito","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/bs.acc.2025.10.008_bib204","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/cr.2008.37","article-title":"The roles of MAPKs in disease","volume":"18","author":"Lawrence","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib205","first-page":"741","article-title":"Trametinib: a targeted therapy in metastatic melanoma","volume":"9","author":"Hoffner","year":"2018","journal-title":"J.\u00a0Adv. Pract. Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib206","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1159\/000490022","article-title":"Efficacy of the MEK inhibitor cobimetinib and its potential application to colorectal cancer cells","volume":"47","author":"Gong","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/bs.acc.2025.10.008_bib207","doi-asserted-by":"crossref","DOI":"10.1177\/1073274820983013","article-title":"Targeting BRAF-mutant biliary tract cancer: recent advances and future challenges","volume":"27","author":"Rizzo","year":"2020","journal-title":"Cancer Control"},{"key":"10.1016\/bs.acc.2025.10.008_bib208","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jcmgh.2021.05.011","article-title":"Anti-PD-1 in combination with trametinib suppresses tumor growth and improves survival of intrahepatic cholangiocarcinoma in mice","volume":"12","author":"Wabitsch","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib209","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S1470-2045(20)30321-1","article-title":"Dabrafenib plus trametinib in patients with BRAF(V600E)-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial","volume":"21","author":"Subbiah","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib210","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152670","article-title":"Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers","volume":"131","author":"Yarchoan","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/bs.acc.2025.10.008_bib211","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1158\/2159-8290.CD-19-1265","article-title":"Pan-cancer efficacy of vemurafenib in BRAF (V600)-mutant non-melanoma cancers","volume":"10","author":"Subbiah","year":"2020","journal-title":"Cancer Disc."},{"key":"10.1016\/bs.acc.2025.10.008_bib212","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12964-022-00989-y","article-title":"PI3K\/AKT signaling allows for MAPK\/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma","volume":"20","author":"Corrales","year":"2022","journal-title":"Cell Comm. Signal"},{"key":"10.1016\/bs.acc.2025.10.008_bib213","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal.\u00a0Trans. Targeted Ther."},{"key":"10.1016\/bs.acc.2025.10.008_bib214","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.molcel.2015.03.015","article-title":"Dishevelled promotes Wnt receptor degradation through recruitment of ZNRF3\/RNF43 E3 ubiquitin ligases","volume":"58","author":"Jiang","year":"2015","journal-title":"Mol.\u00a0Cell."},{"key":"10.1016\/bs.acc.2025.10.008_bib215","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-Catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"10.1016\/bs.acc.2025.10.008_bib216","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0167-4889(99)00158-5","article-title":"Biochemical interactions in the wnt pathway","volume":"1495","author":"Seidensticker","year":"2000","journal-title":"Biochim.\u00a0Biophys. Acta"},{"key":"10.1016\/bs.acc.2025.10.008_bib217","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.cellsig.2009.11.021","article-title":"Dishevelled: The hub of Wnt signaling","volume":"22","author":"Gao","year":"2010","journal-title":"Cell Signal"},{"key":"10.1016\/bs.acc.2025.10.008_bib218","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1124\/pr.57.2.5","article-title":"International Union of Pharmacology. XLVI. G protein-coupled receptor list","volume":"57","author":"Foord","year":"2005","journal-title":"Pharmacol Rev."},{"key":"10.1016\/bs.acc.2025.10.008_bib219","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/hep.26721","article-title":"Global alterations of DNA methylation in cholangiocarcinoma target the Wnt ignaling pathway","volume":"59","author":"Goeppert","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/bs.acc.2025.10.008_bib220","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3390\/cells12081141","article-title":"Impact of aberrant \u03b2-catenin pathway on cholangiocarcinoma heterogeneity","volume":"12","author":"Lozano","year":"2023","journal-title":"Cells"},{"key":"10.1016\/bs.acc.2025.10.008_bib221","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ejso.2016.11.017","article-title":"Loss of Secreted Frizzled-Related Protein-1 expression is associated with poor prognosis in intrahepatic cholangiocarcinoma","volume":"43","author":"Davaadorj","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib222","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jhep.2017.02.017","article-title":"SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma","volume":"67","author":"Merino-Azpitarte","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib223","article-title":"Wnt\/\u03b2-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma","volume":"40","author":"Zhang","year":"2020","journal-title":"Biosci.\u00a0Rep."},{"key":"10.1016\/bs.acc.2025.10.008_bib224","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1007\/s13277-014-1698-2","article-title":"Activated macrophages promote Wnt\/\u03b2-catenin signaling in cholangiocarcinoma cells","volume":"35","author":"Loilome","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/bs.acc.2025.10.008_bib225","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1091\/mbc.e08-05-0506","article-title":"Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3","volume":"19","author":"Medici","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/bs.acc.2025.10.008_bib226","first-page":"13","article-title":"The epithelial-mesenchymal transition induced by transcription factor LEF-1 is independent of \u03b2-catenin","volume":"15","author":"Kobayashi","year":"2018","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/bs.acc.2025.10.008_bib227","doi-asserted-by":"crossref","first-page":"42276","DOI":"10.18632\/oncotarget.5514","article-title":"Involvement of Wnt\/\u03b2-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/bs.acc.2025.10.008_bib228","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3892\/ijo.2020.5074","article-title":"Targeting cancer stem cells in cholangiocarcinoma (Review)","volume":"57","author":"Mcgrath","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib229","first-page":"30","article-title":"Cholangiocarcinoma tumor microenvironment highlighting fibrosis and matrix components","volume":"9","author":"Caligiuri","year":"2023","journal-title":"Hepatoma Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib230","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/cancers11060771","article-title":"A review of the role of wnt in cancer immunomodulation","volume":"11","author":"Goldsberry","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/bs.acc.2025.10.008_bib231","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrd4233","article-title":"Can we safely target the WNT pathway?","volume":"13","author":"Kahn","year":"2014","journal-title":"Nature Rev Drug Disc"},{"key":"10.1016\/bs.acc.2025.10.008_bib232","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/prot.20955","article-title":"Inhibition of protein-protein interactions: the discovery of druglike beta-catenin inhibitors by combining virtual and biophysical screening","volume":"64","author":"Trosset","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/bs.acc.2025.10.008_bib233","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nature08356","article-title":"Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling","volume":"461","author":"Huang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/bs.acc.2025.10.008_bib234","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nrd3868","article-title":"Tankyrase-targeted therapeutics: expanding opportunities in the PARP family","volume":"11","author":"Riffell","year":"2012","journal-title":"Nature Rev Drug Disc"},{"key":"10.1016\/bs.acc.2025.10.008_bib235","doi-asserted-by":"crossref","first-page":"11717","DOI":"10.1073\/pnas.1120068109","article-title":"Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors","volume":"109","author":"Gurney","year":"2012","journal-title":"Proc\u00a0Nat Acad Sci USA"},{"key":"10.1016\/bs.acc.2025.10.008_bib236","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10549-020-05817-w","article-title":"Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer","volume":"184","author":"Diamond","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/bs.acc.2025.10.008_bib237","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2853","article-title":"TGF-beta signalling: a complex web in cancer progression","volume":"10","author":"Ikushima","year":"2010","journal-title":"Nature Rev Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib238","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ng1001-117","article-title":"TGF-beta signaling in tumor suppression and cancer progression","volume":"29","author":"Derynck","year":"2001","journal-title":"Nature Gen"},{"key":"10.1016\/bs.acc.2025.10.008_bib239","doi-asserted-by":"crossref","first-page":"a022061","DOI":"10.1101\/cshperspect.a022061","article-title":"TGF-\u03b2 signaling from receptors to smads","volume":"8","author":"Hata","year":"2016","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"10.1016\/bs.acc.2025.10.008_bib240","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1093\/emboj\/16.17.5353","article-title":"TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4","volume":"16","author":"Nakao","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/bs.acc.2025.10.008_bib241","article-title":"Transforming growth factor-beta (TGF-\u03b2) signaling in cancer-a betrayal within","volume":"13","author":"Baba","year":"2022","journal-title":"Front.\u00a0Pharmacol."},{"key":"10.1016\/bs.acc.2025.10.008_bib242","doi-asserted-by":"crossref","first-page":"a022277","DOI":"10.1101\/cshperspect.a022277","article-title":"TGF-\u03b2 Family signaling in tumor suppression and cancer progression","volume":"9","author":"Seoane","year":"2017","journal-title":"Cold Spring Harbor Perspect.\u00a0Biol."},{"key":"10.1016\/bs.acc.2025.10.008_bib243","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/bjc.2011.452","article-title":"E\/N-cadherin switch mediates cancer progression via TGF-\u03b2-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma","volume":"105","author":"Araki","year":"2011","journal-title":"Brit.\u00a0J. Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib244","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.3390\/jcm11216498","article-title":"Cancer-associated fibroblasts in cholangiocarcinoma: current knowledge and possible implications for therapy","volume":"11","author":"Montori","year":"2022","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/bs.acc.2025.10.008_bib245","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ajpath.2024.07.009","article-title":"Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma: insights into origins, heterogeneity, lymphangiogenesis, and peritoneal metastasis","volume":"195","author":"Aff\u1f78","year":"2025","journal-title":"Am. J.\u00a0Pathol."},{"key":"10.1016\/bs.acc.2025.10.008_bib246","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13071-024-06236-2","article-title":"The crosstalk between cholangiocytes and hepatic stellate cells promotes the progression of epithelial-mesenchymal transition and periductal fibrosis during Clonorchis sinensis infection","volume":"17","author":"Yi","year":"2024","journal-title":"Parasites Vectors"},{"key":"10.1016\/bs.acc.2025.10.008_bib247","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/cancers17030514","article-title":"Cross-talk between tumor cells and stellate cells promotes oncolytic VSV activity in intrahepatic cholangiocarcinoma","volume":"17","author":"Neumeyer","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/bs.acc.2025.10.008_bib248","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance","volume":"8","author":"Thomas","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.acc.2025.10.008_bib249","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aad1884","article-title":"TGF-\u03b2 inhibits the activation and functions of NK cells by repressing the mTOR pathway","volume":"9","author":"Viel","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/bs.acc.2025.10.008_bib250","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/jid.2011.416","article-title":"Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas","volume":"132","author":"Fujimura","year":"2012","journal-title":"J.\u00a0Invest Dermatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib251","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1186\/s12885-023-11153-1","article-title":"A phase Ib\/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer","volume":"23","author":"Nadal","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib252","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/bs.acc.2025.10.008_bib253","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-024-01828-x","article-title":"Notch signaling pathway in cancer: from mechanistic insights to targeted therapies","volume":"9","author":"Shi","year":"2024","journal-title":"Signal. Trans. Target Ther."},{"key":"10.1016\/bs.acc.2025.10.008_bib254","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2020.10.027","article-title":"Turning up our understanding of liver cancer by a notch","volume":"74","author":"Lujambio","year":"2021","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib255","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.semcdb.2012.01.009","article-title":"Notch receptor-ligand binding and activation: insights from molecular studies","volume":"23","author":"Chillakuri","year":"2012","journal-title":"Sem.\u00a0Cell Dev.\u00a0Biol."},{"key":"10.1016\/bs.acc.2025.10.008_bib256","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-biophys-101920-082204","article-title":"Biophysics of notch signaling","volume":"50","author":"Sprinzak","year":"2021","journal-title":"Ann.\u00a0Rev. Biophys."},{"key":"10.1016\/bs.acc.2025.10.008_bib257","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1007\/s00018-008-7586-4","article-title":"ADAM proteases: ligand processing and modulation of the Notch pathway","volume":"65","author":"Zolkiewska","year":"2008","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/bs.acc.2025.10.008_bib258","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1101\/gad.942302","article-title":"Kuzbanian-mediated cleavage of Drosophila Notch","volume":"16","author":"Lieber","year":"2002","journal-title":"Genes. Dev."},{"key":"10.1016\/bs.acc.2025.10.008_bib259","first-page":"147","article-title":"Notch signaling in context: basic and translational implications","volume":"131","author":"Aster","year":"2020","journal-title":"Trans.\u00a0Am. Clin. Climatolog. Assn."},{"key":"10.1016\/bs.acc.2025.10.008_bib260","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","article-title":"The canonical Notch signaling pathway: unfolding the activation mechanism","volume":"137","author":"Kopan","year":"2009","journal-title":"Cell"},{"key":"10.1016\/bs.acc.2025.10.008_bib261","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.048413","article-title":"The developmental origins of Notch-driven intrahepatic bile duct disorders","volume":"14","author":"Martinez Lyons","year":"2021","journal-title":"Dis. Models Mech."},{"key":"10.1016\/bs.acc.2025.10.008_bib262","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1242\/dev.029140","article-title":"Notch signaling controls liver development by regulating biliary differentiation","volume":"136","author":"Zong","year":"2009","journal-title":"Development"},{"key":"10.1016\/bs.acc.2025.10.008_bib263","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nature Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib264","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1186\/s12885-016-2919-4","article-title":"Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties","volume":"16","author":"Aoki","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib265","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/labinvest.2017.29","article-title":"The hippo signaling functions through the Notch signaling to regulate intrahepatic bile duct development in mammals","volume":"97","author":"Wu","year":"2017","journal-title":"Lab Invest."},{"key":"10.1016\/bs.acc.2025.10.008_bib266","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","article-title":"Notch signaling pathway: architecture, disease, and therapeutics","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Trans. Targeted Ther."},{"key":"10.1016\/bs.acc.2025.10.008_bib267","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1038\/s41467-020-15729-4","article-title":"Using apelin-based synthetic Notch receptors to detect angiogenesis and treat solid tumors","volume":"11","author":"Wang","year":"2020","journal-title":"Nature Comm."},{"key":"10.1016\/bs.acc.2025.10.008_bib268","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1078-0432.CCR-22-1366","article-title":"Molecular mechanisms and future implications of VEGF\/VEGFR in cancer therapy","volume":"29","author":"Patel","year":"2023","journal-title":"Clin.\u00a0Cancer Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib269","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.tcb.2018.03.001","article-title":"Crosstalk between YAP\/TAZ and notch signaling","volume":"28","author":"Totaro","year":"2018","journal-title":"Trends Cell Biol."},{"key":"10.1016\/bs.acc.2025.10.008_bib270","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022137","article-title":"Signaling cross talk between TGF-\u03b2\/Smad and other signaling pathways","volume":"9","author":"Luo","year":"2017","journal-title":"Cold Spring Harbor Perspect Biol."},{"key":"10.1016\/bs.acc.2025.10.008_bib271","article-title":"Crosstalk between the circadian clock, intestinal stem cell niche, and epithelial cell fate decision","author":"Liu","year":"2025","journal-title":"Genes Dis."},{"key":"10.1016\/bs.acc.2025.10.008_bib272","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.3390\/cancers15184563","article-title":"Modulation of notch signaling by small-molecular compounds and its potential in anticancer studies","volume":"15","author":"Czerwonka","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/bs.acc.2025.10.008_bib273","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-22-0243","article-title":"Targeting the DLL\/Notch signaling pathway in cancer: challenges and advances in clinical development","volume":"22","author":"You","year":"2023","journal-title":"Mol.\u00a0Cancer Ther."},{"key":"10.1016\/bs.acc.2025.10.008_bib274","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.30816","article-title":"Identification of a pan-gamma-secretase inhibitor response signature for notch-driven cholangiocarcinoma","volume":"71","author":"O\u2019Rourke","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/bs.acc.2025.10.008_bib275","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/0192623313486315","article-title":"Intermittent oral coadministration of a gamma secretase inhibitor with dexamethasone mitigates intestinal goblet cell hyperplasia in rats","volume":"42","author":"Aguirre","year":"2014","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/bs.acc.2025.10.008_bib276","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.scr.2009.09.002","article-title":"Role of\u00a0Sonic hedgehog signaling and the expression of its components in human embryonic stem cells","volume":"4","author":"Wu","year":"2010","journal-title":"Stem Cell Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib277","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1242\/dev.083691","article-title":"Roles for Hedgehog signaling in adult organ homeostasis and repair","volume":"141","author":"Petrova","year":"2014","journal-title":"Development"},{"key":"10.1016\/bs.acc.2025.10.008_bib278","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41392-023-01559-5","article-title":"Hedgehog signaling in tissue homeostasis, cancers, and targeted therapies","volume":"8","author":"Jing","year":"2023","journal-title":"Signal Trans. Targeted Ther."},{"key":"10.1016\/bs.acc.2025.10.008_bib279","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1245\/s10434-014-3531-y","article-title":"Hedgehog signaling between cancer cells and hepatic stellate cells in promoting cholangiocarcinoma","volume":"21","author":"Kim","year":"2014","journal-title":"Ann. Surg.\u00a0Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib280","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.3390\/cancers13194774","article-title":"The role of the Hedgehog pathway in cholangiocarcinoma","volume":"13","author":"Anichini","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/bs.acc.2025.10.008_bib281","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106564","article-title":"SHH\/GLI2-TGF-\u03b21 feedback loop between cancer cells and tumor-associated macrophages maintains epithelial-mesenchymal transition and endoplasmic reticulum homeostasis in cholangiocarcinoma","volume":"187","author":"Chen","year":"2023","journal-title":"Pharmacol Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib282","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jhbp.107","article-title":"Hedgehog pathway as a potential treatment target in human cholangiocarcinoma","volume":"21","author":"Riedlinger","year":"2014","journal-title":"J. Hepato-Biliary-Pancreatic Sci."},{"key":"10.1016\/bs.acc.2025.10.008_bib283","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1038\/s41467-018-05220-6","article-title":"Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer","volume":"9","author":"Cazet","year":"2018","journal-title":"Nature Comm."},{"key":"10.1016\/bs.acc.2025.10.008_bib284","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1470-2045(17)30072-4","article-title":"Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial","volume":"18","author":"Dr\u00e9no","year":"2017","journal-title":"Lancet. Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib285","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1158\/1078-0432.CCR-13-1425","article-title":"Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study","volume":"19","author":"Gajjar","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib286","first-page":"1842","article-title":"DHH is an independent prognosticator of oncologic outcome of clear cell renal cell carcinoma","volume":"192","author":"J\u00e4ger","year":"2014","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/bs.acc.2025.10.008_bib287","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s10637-017-0454-z","article-title":"Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors","volume":"35","author":"Stathis","year":"2017","journal-title":"Invest New Drugs"},{"key":"10.1016\/bs.acc.2025.10.008_bib288","first-page":"13214","article-title":"Pharmacological inhibition of sonic hedgehog signaling suppresses tumor development in a Murine model of intrahepatic cholangiocarcinoma","volume":"22","author":"Cho","year":"2021","journal-title":"Int.\u00a0J.\u00a0Mol. Sci."},{"key":"10.1016\/bs.acc.2025.10.008_bib289","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.3390\/cancers15204947","article-title":"Primary sclerosing cholangitis-associated cholangiocarcinoma: from pathogenesis to diagnostic and surveillance strategies","volume":"15","author":"Catanzaro","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/bs.acc.2025.10.008_bib290","first-page":"184","article-title":"Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism","volume":"60","author":"Jaiswal","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/bs.acc.2025.10.008_bib291","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/gast.2001.20875","article-title":"Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes","volume":"120","author":"Jaiswal","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.acc.2025.10.008_bib292","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/hep.31829","article-title":"Genetic determinants of outcome in intrahepatic cholangiocarcinoma","volume":"74","author":"Boerner","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/bs.acc.2025.10.008_bib293","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1053\/gast.2002.32410","article-title":"Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line","volume":"122","author":"Yoon","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.acc.2025.10.008_bib294","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jhep.2004.07.016","article-title":"Enhanced epidermal growth factor receptor activation in human cholangiocarcinoma cells","volume":"41","author":"Yoon","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib295","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/hep.20125","article-title":"Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: implications for biliary tract carcinogenesis","volume":"39","author":"Yoon","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/bs.acc.2025.10.008_bib296","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1172\/JCI73742","article-title":"Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation","volume":"124","author":"Li","year":"2014","journal-title":"J.\u00a0Clin.\u00a0Invest"},{"key":"10.1016\/bs.acc.2025.10.008_bib297","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/hep.510300522","article-title":"Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line","volume":"30","author":"Park","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/bs.acc.2025.10.008_bib298","doi-asserted-by":"crossref","first-page":"13418","DOI":"10.3748\/wjg.v21.i48.13418","article-title":"Hepatolithiasis and intrahepatic cholangiocarcinoma: a review","volume":"21","author":"Kim","year":"2015","journal-title":"World J.\u00a0Gastroenterol."},{"key":"10.1016\/bs.acc.2025.10.008_bib299","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/cells8101172","article-title":"Mitogen-activated protein kinases (MAPKs) and cholangiocarcinoma: the missing link","volume":"8","author":"Chen","year":"2019","journal-title":"Cells"},{"key":"10.1016\/bs.acc.2025.10.008_bib300","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1542-3565(03)00133-2","article-title":"Prostaglandin E receptors in bile ducts of hepatolithiasis patients and the pathobiological significance for cholangitis","volume":"1","author":"Shoda","year":"2003","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib301","first-page":"52","article-title":"Expression of epidermal growth factor receptor, ErbB2 and matrix metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma","volume":"45","author":"Kim","year":"2005","journal-title":"Korean J. Gastroenterol."},{"key":"10.1016\/bs.acc.2025.10.008_bib302","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000354341","article-title":"Expression levels and significance of nuclear factor-\u03baB and epidermal growth factor receptor in hepatolithiasis associated with intrahepatic cholangiocarcinoma","volume":"30","author":"Zhou","year":"2013","journal-title":"Digest. Surg."},{"issue":"9","key":"10.1016\/bs.acc.2025.10.008_bib303","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/hep4.2003","article-title":"A prospective investigation of serum bile acids with risk of liver cancer, fatal liver disease, and biliary tract cancer","volume":"6","author":"Farhat","year":"2022","journal-title":"Hepatol. Comm."},{"key":"10.1016\/bs.acc.2025.10.008_bib304","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00018-022-04278-2","article-title":"The role of bile acids in carcinogenesis","volume":"79","author":"Re\u017een","year":"2022","journal-title":"Cell Mol.\u00a0Life Sci."},{"key":"10.1016\/bs.acc.2025.10.008_bib305","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/aps.2014.117","article-title":"FXR and liver carcinogenesis","volume":"36","author":"Huang","year":"2015","journal-title":"Acta Pharmacol Sinica."},{"key":"10.1016\/bs.acc.2025.10.008_bib306","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1194\/jlr.M700330-JLR200","article-title":"Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine","volume":"48","author":"Kim","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib307","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.22519","article-title":"Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response","volume":"48","author":"Wang","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/bs.acc.2025.10.008_bib308","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep.27085","article-title":"Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2","volume":"60","author":"Liu","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/bs.acc.2025.10.008_bib309","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gutjnl-2015-309458","article-title":"TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro","volume":"65","author":"Reich","year":"2016","journal-title":"Gut"},{"key":"10.1016\/bs.acc.2025.10.008_bib310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132673","article-title":"Association between liver fluke infection and hepatobiliary pathological changes: a systematic review and meta-analysis","volume":"10","author":"Xia","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/bs.acc.2025.10.008_bib311","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5009\/gnl17102","article-title":"Liver fluke-associated biliary tract cancer","volume":"12","author":"Prueksapanich","year":"2018","journal-title":"Gut Liver"},{"key":"10.1016\/bs.acc.2025.10.008_bib312","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040201","article-title":"Liver fluke induces cholangiocarcinoma","volume":"4","author":"Sripa","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/bs.acc.2025.10.008_bib313","first-page":"95","article-title":"Human pathology of Opisthorchis viverrini infection: a comparison of adults and children","volume":"20","author":"Riganti","year":"1989","journal-title":"Southeast Asian J.\u00a0Trop. Med. Public Health"},{"key":"10.1016\/bs.acc.2025.10.008_bib314","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0166-6851(86)90094-0","article-title":"Types of collagen in Opisthorchis viverrini infected hamster liver","volume":"18","author":"Chotigeat","year":"1986","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/bs.acc.2025.10.008_bib315","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0016-5107(87)71478-3","article-title":"Peritoneoscopic findings in 203 patients with Opisthorchis viverrini infection","volume":"33","author":"Hitanant","year":"1987","journal-title":"Gastroint Endos."},{"key":"10.1016\/bs.acc.2025.10.008_bib316","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3835(94)90040-X","article-title":"Strong promoting effect of Opisthorchis viverrini infection on imethylnitrosamine-initiated hamster liver","volume":"78","author":"Thamavit","year":"1994","journal-title":"Cancer Lett."},{"key":"10.1016\/bs.acc.2025.10.008_bib317","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.parint.2010.09.008","article-title":"Opisthorchis viverrini excretory\/secretory products induce toll-like receptor 4 upregulation and production of interleukin 6 and 8 in cholangiocyte","volume":"59","author":"Ninlawan","year":"2010","journal-title":"Parasitol.\u00a0Int."},{"key":"10.1016\/bs.acc.2025.10.008_bib318","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001654","article-title":"Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini","volume":"6","author":"Sripa","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/bs.acc.2025.10.008_bib319","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","article-title":"A compendium of mutational cancer driver genes","volume":"20","author":"Mart\u00ednez-Jim\u00e9nez","year":"2020","journal-title":"Nature Rev. Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib320","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/ng1972","article-title":"A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing","volume":"39","author":"Ohm","year":"2007","journal-title":"Nature Gen"},{"key":"10.1016\/bs.acc.2025.10.008_bib321","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ng1950","article-title":"Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer","volume":"39","author":"Schlesinger","year":"2007","journal-title":"Nature Gen."},{"key":"10.1016\/bs.acc.2025.10.008_bib322","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ebiom.2016.04.034","article-title":"Tissue microbiome profiling identifies an enrichment of specific enteric bacteria in opisthorchis viverrini associated cholangiocarcinoma","volume":"8","author":"Chng","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/bs.acc.2025.10.008_bib323","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.7314\/APJCP.2015.16.5.1751","article-title":"The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter","volume":"16","author":"Deenonpoe","year":"2015","journal-title":"Asian Pacific J. Cancer. Prevention."},{"key":"10.1016\/bs.acc.2025.10.008_bib324","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00436-014-4230-0","article-title":"Clonorchis sinensis ferritin heavy chain triggers free radicals and mediates inflammation signaling in human hepatic stellate cells","volume":"114","author":"Mao","year":"2015","journal-title":"Parasitol.\u00a0Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib325","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/ng.2273","article-title":"Exome sequencing of liver fluke-associated cholangiocarcinoma","volume":"44","author":"Ong","year":"2012","journal-title":"Nature Gen."},{"key":"10.1016\/bs.acc.2025.10.008_bib326","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.3748\/wjg.v27.i27.4252","article-title":"Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence?","volume":"27","author":"Fragkou","year":"2021","journal-title":"World J.\u00a0Gastroenterol."},{"key":"10.1016\/bs.acc.2025.10.008_bib327","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.18632\/oncotarget.27002","article-title":"Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinoma","volume":"10","author":"Pollicino","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/bs.acc.2025.10.008_bib328","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12885-019-5391-0","article-title":"Molecular pathogenesis of cholangiocarcinoma","volume":"19","author":"Labib","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib329","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/bs.acc.2025.10.008_bib330","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1440-1746.2010.06546.x","article-title":"Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma","volume":"26","author":"Kew","year":"2011","journal-title":"J.\u00a0Gastroenterol.\u00a0Hepatol"},{"key":"10.1016\/bs.acc.2025.10.008_bib331","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.24675","article-title":"Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice","volume":"55","author":"Wang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/bs.acc.2025.10.008_bib332","first-page":"127","article-title":"Expression and significance of hepatitis B virus genes in human primary intrahepatic cholangiocarcinoma and its surrounding tissue","volume":"18","author":"Wang","year":"1996","journal-title":"Chinese J.\u00a0Oncology."},{"key":"10.1016\/bs.acc.2025.10.008_bib333","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/modpathol.2011.41","article-title":"Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression","volume":"24","author":"Yu","year":"2011","journal-title":"Mod.\u00a0Pathol."},{"key":"10.1016\/bs.acc.2025.10.008_bib334","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12072-017-9829-7","article-title":"Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread","volume":"11","author":"Karayiannis","year":"2017","journal-title":"Hepatol. Int."},{"key":"10.1016\/bs.acc.2025.10.008_bib335","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2893.2010.01315.x","article-title":"Control of hepatitis B virus at the level of transcription","volume":"17","author":"Quasdorff","year":"2010","journal-title":"J. Viral Hepatitis"},{"key":"10.1016\/bs.acc.2025.10.008_bib336","first-page":"6601","volume":"10","author":"Liu","year":"2017","journal-title":"Combined hepatocellular and cholangiocarcinoma: WHO classification-based analysis of long-term prognosis after surgery"},{"key":"10.1016\/bs.acc.2025.10.008_bib337","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1172\/JCI63065","article-title":"Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes","volume":"122","author":"Sekiya","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.acc.2025.10.008_bib338","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1172\/JCI63212","article-title":"Cholangiocarcinomas can originate from hepatocytes in mice","volume":"122","author":"Fan","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.acc.2025.10.008_bib339","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1038\/s41388-018-0188-1","article-title":"Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice","volume":"37","author":"Wang","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/bs.acc.2025.10.008_bib340","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41586-018-0519-y","article-title":"Necroptosis microenvironment directs lineage commitment in liver cancer","volume":"562","author":"Seehawer","year":"2018","journal-title":"Nature"},{"key":"10.1016\/bs.acc.2025.10.008_bib341","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1471-2407-12-289","article-title":"Hepatitis virus infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis","volume":"12","author":"Zhou","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib342","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12957-015-0583-9","article-title":"Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies","volume":"13","author":"Li","year":"2015","journal-title":"World J.\u00a0Surg. Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib343","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cgh.2007.05.020","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study","volume":"5","author":"Welzel","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib344","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1349-7006.2004.tb02492.x","article-title":"Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma","volume":"95","author":"Yamamoto","year":"2004","journal-title":"Cancer Sci."},{"key":"10.1016\/bs.acc.2025.10.008_bib345","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1099\/vir.0.80882-0","article-title":"Continuous release of hepatitis C virus (HCV) by peripheral blood mononuclear cells and B-lymphoblastoid cell-line cultures derived from HCV-infected patients","volume":"86","author":"Bar\u00e9","year":"2005","journal-title":"J Gen. Virol."},{"key":"10.1016\/bs.acc.2025.10.008_bib346","first-page":"737","article-title":"Detection of HCV in bile duct epithelium by laser capture microdissection (LCM)","volume":"19","author":"Fillipowicz","year":"2005","journal-title":"In Vivo"},{"key":"10.1016\/bs.acc.2025.10.008_bib347","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/JVI.00417-10","article-title":"Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122","volume":"84","author":"Jangra","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/bs.acc.2025.10.008_bib348","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056272","article-title":"MicroRNA-122 dependent binding of Ago2 protein to hepatitis C virus RNA is associated with enhanced RNA stability and translation stimulation","volume":"8","author":"Conrad","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/bs.acc.2025.10.008_bib349","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1245\/s10434-010-0925-3","article-title":"Epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma","volume":"17","author":"Li","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib350","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1038\/labinvest.2010.147","article-title":"Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma","volume":"90","author":"Pereira","year":"2010","journal-title":"Lab Invest."},{"key":"10.1016\/bs.acc.2025.10.008_bib351","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/hep.24466","article-title":"Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization","volume":"54","author":"Fabris","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/bs.acc.2025.10.008_bib352","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jhep.2013.07.036","article-title":"HCV core-mediated activation of latent TGF-\u03b2 via thrombospondin drives the crosstalk between hepatocytes and stromal environment","volume":"59","author":"Benzoubir","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib353","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3390\/jcm4121958","article-title":"Epithelial-to-mesenchymal transition and cancer invasiveness: what can we learn from cholangiocarcinoma?","volume":"4","author":"Brivio","year":"2015","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/bs.acc.2025.10.008_bib354","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1242\/jcs.00224","article-title":"The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors","volume":"116","author":"Bol\u00f3s","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/bs.acc.2025.10.008_bib355","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jhep.2016.09.010","article-title":"Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks","volume":"66","author":"Vaquero","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib356","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/labinvest.3700704","article-title":"Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease","volume":"88","author":"Rygiel","year":"2008","journal-title":"Lab Invest"},{"key":"10.1016\/bs.acc.2025.10.008_bib357","article-title":"MicroRNA125b-mediated Hedgehog signaling influences liver regeneration by chorionic plate-derived mesenchymal stem cells","volume":"5","author":"Hyun","year":"2015","journal-title":"Sci.\u00a0Rep."},{"key":"10.1016\/bs.acc.2025.10.008_bib358","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1289\/ehp.7351","article-title":"Dose-additive carcinogenicity of a defined mixture of \u201cdioxin-like compounds","volume":"113","author":"Walker","year":"2005","journal-title":"Environ.\u00a0Health Perspect."},{"key":"10.1016\/bs.acc.2025.10.008_bib359","first-page":"934","article-title":"Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes","volume":"65","author":"Andrieux","year":"2004","journal-title":"Mol.\u00a0Pharmacol."},{"key":"10.1016\/bs.acc.2025.10.008_bib360","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1097\/MPA.0000000000002357","article-title":"Aryl hydrocarbon receptor knockout accelerates PanIN formation and fibro-inflammation in a mutant kras -driven pancreatic cancer model","volume":"53","author":"Walcheck","year":"2024","journal-title":"Pancreas"},{"key":"10.1016\/bs.acc.2025.10.008_bib361","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.3390\/cimb45050248","article-title":"AhR and Wnt\/\u03b2-catenin signaling pathways and their interplay","volume":"45","author":"Grishanova","year":"2023","journal-title":"Curr.\u00a0Issues Mol. Biol."},{"key":"10.1016\/bs.acc.2025.10.008_bib362","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3390\/cells9020421","article-title":"Asbestos and intrahepatic cholangiocarcinoma","volume":"9","author":"Brandi","year":"2020","journal-title":"Cells"},{"key":"10.1016\/bs.acc.2025.10.008_bib363","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/MEG.0000000000000357","article-title":"Asbestos fibers in the gallbladder of patients affected by benign biliary tract diseases","volume":"27","author":"Grosso","year":"2015","journal-title":"Eur J. Gastroenterol.\u00a0Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib364","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0013-9351(83)90213-X","article-title":"Asbestos bodies in a bile duct cancer after occupational exposure","volume":"30","author":"Szendr\u00f6i","year":"1983","journal-title":"Environ. Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib365","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1567-5769(01)00172-2","article-title":"Diseases caused by asbestos: mechanisms of injury and disease development","volume":"2","author":"Manning","year":"2002","journal-title":"Int.\u00a0Immunopharmacol."},{"key":"10.1016\/bs.acc.2025.10.008_bib366","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/08958378.2000.11463240","article-title":"Role of mitogen-activated protein kinases, early response protooncogenes, and activator protein-1 in cell signaling by asbestos","volume":"12","author":"Mossman","year":"2000","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/bs.acc.2025.10.008_bib367","first-page":"23","article-title":"Targeting MAPK signaling in age-related macular degeneration","volume":"8","author":"Kyosseva","year":"2016","journal-title":"Ophthalmol.\u00a0Eye. Dis."},{"key":"10.1016\/bs.acc.2025.10.008_bib368","first-page":"195","article-title":"Exposure to aflatoxin B1 in animal-feed production plant workers","volume":"99","author":"Autrup","year":"1993","journal-title":"Environ. Health Perspect"},{"key":"10.1016\/bs.acc.2025.10.008_bib369","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.mam.2012.08.001","article-title":"Cardiovascular epigenetics: from DNA methylation to microRNAs","volume":"34","author":"Udali","year":"2013","journal-title":"Mol Aspects Med."},{"key":"10.1016\/bs.acc.2025.10.008_bib370","doi-asserted-by":"crossref","DOI":"10.1177\/1010428318777344","article-title":"Participation of liver stem cells in cholangiocarcinogenesis after aflatoxin B(1) exposure of glutathione S-transferase A3 knockout mice","volume":"40","author":"Ilic","year":"2018","journal-title":"Tumour Biol."},{"key":"10.1016\/bs.acc.2025.10.008_bib371","first-page":"295","article-title":"Preformed N-nitroso compounds in foods and beverages","volume":"8","author":"Hotchkiss","year":"1989","journal-title":"Cancer Surv."},{"key":"10.1016\/bs.acc.2025.10.008_bib372","first-page":"4559","article-title":"Metabolic activation and DNA interactions of carcinogenic N-nitrosamines to which humans are commonly exposed","volume":"23","author":"Li","year":"2022","journal-title":"Int. J.\u00a0Mol.\u00a0Sci."},{"key":"10.1016\/bs.acc.2025.10.008_bib373","unstructured":"Toxicological Profile for N-Nitrosodimethylamine (NDMA). Agency for Toxic Substances and Disease Registry, Atlanta, GA, 2023."},{"key":"10.1016\/bs.acc.2025.10.008_bib374","first-page":"349","article-title":"Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress","volume":"387","author":"Seitz","year":"2006","journal-title":"Biol.\u00a0Chem."},{"key":"10.1016\/bs.acc.2025.10.008_bib375","first-page":"245","article-title":"Overview: how is alcohol metabolized by the body?","volume":"29","author":"Zakhari","year":"2006","journal-title":"Alcohol Res. Health"},{"key":"10.1016\/bs.acc.2025.10.008_bib376","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbrc.2013.11.057","article-title":"Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease","volume":"443","author":"Wu","year":"2014","journal-title":"Biochem. Biophys. Res. Comm."},{"key":"10.1016\/bs.acc.2025.10.008_bib377","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1096\/fj.13-231860","article-title":"Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption","volume":"27","author":"Xie","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/bs.acc.2025.10.008_bib378","doi-asserted-by":"crossref","first-page":"8211","DOI":"10.2147\/OTT.S184444","article-title":"Alcoholic liver disease and risk of cholangiocarcinoma: a systematic review and meta-analysis","volume":"11","author":"Xiong","year":"2018","journal-title":"Onco.\u00a0Targets Ther."},{"key":"10.1016\/bs.acc.2025.10.008_bib379","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41416-018-0007-z","article-title":"Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project","volume":"118","author":"Petrick","year":"2018","journal-title":"Brit.\u00a0J.\u00a0Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib380","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"57","author":"Palmer","year":"2012","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/bs.acc.2025.10.008_bib381","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12885-015-1158-4","article-title":"Mechanisms of tumor-promoting activities of nicotine in lung cancer: synergistic effects of cell membrane and mitochondrial nicotinic acetylcholine receptors","volume":"15","author":"Chernyavsky","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib382","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3390\/cancers6021138","article-title":"Mechanisms of cancer induction by tobacco-specific NNK and NNN","volume":"6","author":"Xue","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/bs.acc.2025.10.008_bib383","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12885-019-5484-9","article-title":"Is exposure to tobacco associated with extrahepatic cholangiocarcinoma epidemics? A retrospective proportional mortality study in China","volume":"19","author":"Hou","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib384","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000529609","article-title":"Association between smoking cessation and the risk of cholangiocarcinoma and ampulla of vater cancer: a nationwide cohort study","volume":"12","author":"Park","year":"2023","journal-title":"Liver Cancer"},{"key":"10.1016\/bs.acc.2025.10.008_bib385","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/jhbp.125","article-title":"Tumor necrosis factor-\u03b1 modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression","volume":"21","author":"Techasen","year":"2014","journal-title":"J. Hepato-Biliary-Pancreatic Sci."},{"key":"10.1016\/bs.acc.2025.10.008_bib386","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12253-014-9806-6","article-title":"The expression of S100A4 protein in human intrahepatic cholangiocarcinoma: clinicopathologic significance and prognostic value","volume":"21","author":"Tian","year":"2015","journal-title":"Pathol.\u00a0Oncol.\u00a0Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib387","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ajpath.2017.01.011","article-title":"Nicotine promotes cholangiocarcinoma growth in xenograft mice","volume":"187","author":"Mart\u00ednez","year":"2017","journal-title":"Am.\u00a0J.\u00a0Pathol."},{"key":"10.1016\/bs.acc.2025.10.008_bib388","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5114\/aoms.2016.58928","article-title":"Obesity and inflammation: the linking mechanism and the complications","volume":"13","author":"Ellulu","year":"2017","journal-title":"Arch Med.\u00a0Sci."},{"key":"10.1016\/bs.acc.2025.10.008_bib389","doi-asserted-by":"crossref","first-page":"451","DOI":"10.7326\/0003-4819-147-7-200710020-00003","article-title":"Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis","volume":"147","author":"Alvaro","year":"2007","journal-title":"Ann. Int. Med."},{"key":"10.1016\/bs.acc.2025.10.008_bib390","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11523-017-0514-5","article-title":"Insulin-Like Growth Factor (IGF) pathway targeting in cancer: role of the igf axis and opportunities for future combination studies","volume":"12","author":"Simpson","year":"2017","journal-title":"Targeted Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib391","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fendo.2014.00010","article-title":"The emerging role of insulin and insulin-like growth factor signaling in cancer stem cells","volume":"5","author":"Malaguarnera","year":"2014","journal-title":"Front Endocrinol."},{"key":"10.1016\/bs.acc.2025.10.008_bib392","first-page":"298","article-title":"Leptin stimulates the epithelial-mesenchymal transition and pro-angiogenic capability of cholangiocarcinoma cells through the miR-122\/PKM2 axis","volume":"55","author":"Peng","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/bs.acc.2025.10.008_bib393","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1158\/0008-5472.CAN-07-6682","article-title":"Leptin enhances cholangiocarcinoma cell growth","volume":"68","author":"Fava","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/bs.acc.2025.10.008_bib394","article-title":"Altered fatty acid metabolism rewires cholangiocarcinoma stemness features","volume":"6","author":"Lori","year":"2024","journal-title":"JHEP Rep."},{"key":"10.1016\/bs.acc.2025.10.008_bib395","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jhep.2022.04.038","article-title":"Metabolic reprogramming in cholangiocarcinoma","volume":"77","author":"Raggi","year":"2022","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/bs.acc.2025.10.008_bib396","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41419-024-06775-7","article-title":"MAL2 reprograms lipid metabolism in intrahepatic cholangiocarcinoma via EGFR\/SREBP-1 pathway based on single-cell RNA sequencing","volume":"15","author":"Huang","year":"2024","journal-title":"Cell Death Dis."}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242325001040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242325001040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T01:43:56Z","timestamp":1768959836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242325001040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443470943"],"references-count":396,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2025.10.008","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}